Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position
Structure Therapeutics Inc GPCR
$38.69
▼ -2.89%
($-1.15)
Open
$39.01
Prev Close
$39.84
Day Range
$38.27 – $39.80
52W Range
$15.80 – $94.90
Market Cap
$2.75B
Beta
-1.56
EPS (TTM)
$-0.91
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-02-03 |
| Shares Out. | 212,530,000 |
| Website | structuretx.com/ ↗ |
| Phone | 16504571978 |
Structure Therapeutics Inc is a publicly traded company under the ticker symbol GPCR on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for GPCR
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
Structure Therapeutics Amends And Restates Sales Agreement With Leerink Partners LLC And Cantor Fitzgerald & Co. On May 7, 2026; Increases ATM Shares Offering By $150M To Aggregate $400M
Structure Therapeutics Q1 EPS $(0.35), Inline